WHO Okays Dexamethasone for Treatment for Severe Covid-19 Cases

The World Health Organization (WHO) okays the initial trail results from the United Kingdom(UK).

The result shows that dexamethasone, a corticosteroid, can be lifesaving for patients who are critically ill with COVID-19. For patients on ventilators, the treatment was shown to reduce mortality by about one third, and for patients requiring only oxygen, mortality was cut by about one fifth, according to preliminary findings shared with WHO.

In an official statement by the WHO director, Dr Tedros Adhanom Ghebreyesus, “This is the first treatment to be shown to reduce mortality in patients with COVID-19 requiring oxygen or ventilator support.

This is great news and I congratulate the Government of the UK, the University of Oxford, and the many hospitals and patients in the UK who have contributed to this lifesaving scientific breakthrough.”

Read also, World Insist Covid-19 vaccine for everyone 

The steroid dexamethasone has shown to be the first drug to significantly reduce the risk of death among severe Covid-19 cases; according to the initial result published by UK Researchers, describing the steroid as a major breakthrough in the fight against The disease.

A number of existing drugs have been trialled as a treatment against the novel coronavirus, with mixed results.

Trials of treatment of the anti-arthritis drug hydroxychloroquine were halted in several countries after a major study in The Lancet medical journal suggested it showed no benefit among Covid-19 patients and even increased the risk of death.

Dexamethasone is inexpensive and can be used immediately to save lives worldwide

By Denis Chilaka

Denis Chilaka is a passionate blogger and an amazing writer. He is a health enthusiast who loves sharing helpful information that aids healthy living.

One thought on “WHO Okays Dexamethasone for Treatment of Severe Covid-19 Cases”

Leave a Reply

Your email address will not be published. Required fields are marked *